Table 5 Descriptive statistical analysis of hair density (a) and total hair counts (b) between time points in clinical study II.

From: Weekly treatment with SAMiRNA targeting the androgen receptor ameliorates androgenetic alopecia

 

Baseline

8 weeks

16 weeks

24 weeks

(a)

AR68 5 mg/ml (n = 22)

Meana

0.000

0.091

0.159

0.250

SD

0.000

0.294

0.358

0.551

Placebo (n = 21)

Mean

0.000

− 0.095

− 0.071

− 0.071

SD

0.000

0.340

0.396

0.396

p valuec

0.098

0.039*

0.035*

(b)

AR68 5 mg/ml (n = 22)

Mean(n/cm2)b

182.182

189.727

189.909

SD

26.626

27.216

27.154

p valued

 < 0.001***

 < 0.001***

Placebo (n = 21)

Mean(n/cm2)

181.714

185.429

181.524

SD

32.661

35.778

36.371

p value

  1. aIncrement of mean value represents improvement of hair condition on hairline and vertex.
  2. bIncrement of mean value represents improvement of hair counts.
  3. cSignificantly different at *p < 0.05 compared with AR68 5 mg/ml treated group and placebo group at same time point.
  4. dSignificantly different at ***p < 0.001 compared with baseline.